-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OqG1I3jZMmcDIGOi8q9RzHI/jvbMj2B8S+T2r0tiHYfYMVeLYrCwfblRcKqrpOp1 JWeLiwr6HDrYuGyV+6pfwg== 0000897069-05-000627.txt : 20050308 0000897069-05-000627.hdr.sgml : 20050308 20050308184111 ACCESSION NUMBER: 0000897069-05-000627 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050304 FILED AS OF DATE: 20050308 DATE AS OF CHANGE: 20050308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WHEELER BRIAN CENTRAL INDEX KEY: 0001217566 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 05667805 MAIL ADDRESS: STREET 1: 101 NASSAU DR CITY: LAWRENCEVILLE STATE: NJ ZIP: 05648 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019860701 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 sdc939_ex.xml X0202 4 2005-03-04 0 0000722723 HANGER ORTHOPEDIC GROUP INC HGR 0001217566 WHEELER BRIAN 101 NASSAU DR LAWRENCEVILLE NJ 05648 0 1 0 0 VP, Human Resources Common Stock 2005-03-04 4 A 0 10000 6.32 A 18000 D Option to Buy 13.80 2003-12-11 2012-12-11 Common Stock 25000 25000 D Table I of this Form 4 reports the grant of shares of restricted stock pursuant to Rule 16b-3(d) under the Company's 2002 Stock Incentive Plan. The shares are subject to vesting at the rate of twenty-five percent (25%) of the shares on each one (1) year anniversary date of grant. The price on Table I reflects the value of such shares based on the closing sale price of the Company's common stock on the day preceding the date of grant. Includes 8,000 shares of restricted common stock, of which 25% vests on the first anniversary of the date of grant and which cumulatively vests to the extent of 25% each year thereafter. This option becomes exercisable to the extent of 25% on the above date and is cumulatively exercisable to the extent of 25% each year thereafter. Arden T. Phillips, Attorney-in-fact 2005-03-08 -----END PRIVACY-ENHANCED MESSAGE-----